MANUEL
PRAGA TERENTE
Profesor emérito
Hospital Universitari de Bellvitge
l'Hospitalet de Llobregat, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitari de Bellvitge (32)
2024
-
Complement alternative pathway determines disease susceptibility and severity in antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis
Kidney International, Vol. 105, Núm. 1, pp. 177-188
-
Renal Disease in Metabolic Syndrome: the Hidden Role of Intrarenal Ischemia
Kidney International Reports
2023
-
Clinical Profiles and Patterns of Kidney Disease Progression in C3 Glomerulopathy
Kidney360, Vol. 4, Núm. 5, pp. 659-672
-
Consensus document of the Spanish Group for the Study of the Glomerular Diseases (GLOSEN) for the diagnosis and treatment of lupus nephritis
Nefrologia, Vol. 43, Núm. 1, pp. 6-47
2022
-
C3 glomerulopathy associated with monoclonal gammopathy: impact of chronic histologic lesions and beneficial effects of clone-targeted therapies
Nephrology Dialysis Transplantation, Vol. 37, Núm. 11, pp. 2128-2137
-
Development and validation of a nomogram to predict kidney survival at baseline in patients with C3 glomerulopathy
Clinical Kidney Journal, Vol. 15, Núm. 9, pp. 1737-1746
-
Longitudinal change in proteinuria and kidney outcomes in C3 glomerulopathy
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 37, Núm. 7, pp. 1270-1280
2021
-
Quantifying duration of proteinuria remission and association with clinical outcome in IgA nephropathy
Journal of the American Society of Nephrology, Vol. 32, Núm. 2
-
The Role of Vascular Lesions in Diabetes Across a Spectrum of Clinical Kidney Disease
Kidney International Reports, Vol. 6, Núm. 9, pp. 2392-2403
-
Validation of a Histologic Scoring Index for C3 Glomerulopathy
American Journal of Kidney Diseases, Vol. 77, Núm. 5, pp. 684-695.e1
2020
-
Mycophenolate mofetil in c3 glomerulopathy and pathogenic drivers of the disease
Clinical Journal of the American Society of Nephrology, Vol. 15, Núm. 9, pp. 1287-1298
-
Risk factors for non-diabetic renal disease in diabetic patients
Clinical Kidney Journal, Vol. 13, Núm. 3, pp. 380-388
2019
-
Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome
Kidney International, Vol. 96, Núm. 4, pp. 995-1004
2018
-
A retrospective study of pregnancy-associated atypical hemolytic uremic syndrome
Kidney International, Vol. 93, Núm. 2, pp. 450-459
-
Determinants of renal and patient outcomes in a Spanish cohort of patients with ANCA-associated vasculitis and renal involvement
Clinical Rheumatology, Vol. 37, Núm. 4, pp. 1065-1074
-
Paricalcitol Versus Calcifediol for Treating Hyperparathyroidism in Kidney Transplant Recipients
Kidney International Reports, Vol. 3, Núm. 1, pp. 122-132
2017
-
Rituximab for Steroid-Dependent or Frequently Relapsing Idiopathic Nephrotic Syndrome in Adults: A Retrospective, Multicenter Study in Spain
BioDrugs, Vol. 31, Núm. 3, pp. 239-249
2015
-
An update for atypical haemolytic uraemic syndrome: Diagnosis and treatment. A consensus document
Nefrologia
-
Non-proteinuric pathways in loss of renal function in patients with type 2 diabetes
The Lancet Diabetes and Endocrinology